Healthy Subject

Healthy/Normal

27 drugs in development·7 companies·1 clinical trial

Drug Pipeline by Phase

Phase 3(2)

Drug	Company
ac-076 for s.c. administration	Innovation Pharmaceuticals Inc. (IPIX)
cenerimod	Innovation Pharmaceuticals Inc. (IPIX)

Phase 2(4)

Drug	Company
act-246475	Innovation Pharmaceuticals Inc. (IPIX)
selatogrel	Innovation Pharmaceuticals Inc. (IPIX)
tnx-102 sl	Tonix Pharmaceuticals Holding Corp. (TNXP)
tnx-1500	Tonix Pharmaceuticals Holding Corp. (TNXP)

Phase 1(16)

Drug	Company
ac-076 for s.c. administration	Viatris Inc (VTRS)
act-246475	Viatris Inc (VTRS)
act-334441	Viatris Inc (VTRS)
ALPHA-1062 original nasal formulation (Phase I studies)	Alpha Cognition Inc. (ACOG)
combined oral contraceptives	Viatris Inc (VTRS)
combined oral contraceptives	Innovation Pharmaceuticals Inc. (IPIX)
diltiazem er	Viatris Inc (VTRS)
diltiazem er	Innovation Pharmaceuticals Inc. (IPIX)
hec-007	SUNSHINE BIOPHARMA INC. (SBFM)
keyhole limpet hemocyanin	Tonix Pharmaceuticals Holding Corp. (TNXP)
moxifloxacin	Innovation Pharmaceuticals Inc. (IPIX)
moxifloxacin	Viatris Inc (VTRS)
rifampicin	Viatris Inc (VTRS)
rifampicin	Innovation Pharmaceuticals Inc. (IPIX)
selatogrel	Viatris Inc (VTRS)
shr-4597	NYMOX PHARMACEUTICAL CORP (NYMXF)

Phase 1/Phase 2(5)

Drug	Company
act-334441	Innovation Pharmaceuticals Inc. (IPIX)
BEAM-103	Beam Therapeutics Inc. (BEAM)
BEAM-104	Beam Therapeutics Inc. (BEAM)
BEAM-301	Beam Therapeutics Inc. (BEAM)
BEAM-304	Beam Therapeutics Inc. (BEAM)

BioSniper tracks 27 drugs in development for Healthy Subject across 7 companies.

There are 1 clinical trial targeting Healthy Subject tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.